Infrastructure automation technology developer CoreOS, which had raised $48m from investors including GV and Intel Capital, has agreed to an acquistion by Red Hat.

The pruritus treatment developer, which counts Novo and Merck & Co as shareholders, has closed its initial public offering, its shares having almost doubled in price.

The immuno-oncology drug developer, which is backed by Celgene and GV, floated above its range and has since seen its share price rise 75%.

The seed and fertliliser producer, which counts Monsanto as an investor, has set the range for an initial public offering that could net up to $142m.

Skyport Systems had raised $67m in funding from investors including Cisco Investments and was valued at $245m as of 2016.

Michigan’s Armune Bioscience has been bought by Exact Science, which plans to expand its cancer diagnostics range with Armune’s prostate cancer test.

The round will enable medical apparel producer Figs to buy out its earlier investors, which include Crocs, leaving Tulco its only external backer.

Data virtualisation software developer Primary Data is winding down after raising more than $100m in financing from investors including Dell.

99.co has picked up Indonesia-based property listings portal UrbanIndo to expand in Southeast Asia, allowing Gree Ventures to exit.

Rocket Internet-backed online furniture store Home24 is preparing an initial public offering for this coming summer.